U.S. research roundup: Danaher, Illumina, Reliance
DHR•Analysts raised Danaher’s price target to $250 from $215, Illumina’s to $310 from $230 and Reliance’s to $421 from $418. The roundup also included rating and price-target changes for other U.S.-listed companies.
1. Highlighted target changes
RBC raised its price targets for Danaher to $250 from $215 and Illumina to $310 from $230. KeyBanc raised its target for Reliance to $421 from $418.
2. Other analyst actions
The roundup included target increases for EOG Resources, Merck, MetLife, Raymond James Financial, SSR Mining, Wintrust Financial and Zeta Global, and target cuts for several other companies. RBC cut Mosaic to sector perform from outperform and lowered its target to $25 from $27. Jefferies initiated coverage of Samsara with a buy rating and a $50 target.
